We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Outcome After Treatment of Pulmonary Aspergilloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01958710
Recruitment Status : Unknown
Verified October 2013 by Johnny Moons, University Hospital, Gasthuisberg.
Recruitment status was:  Active, not recruiting
First Posted : October 9, 2013
Last Update Posted : October 9, 2013
Information provided by (Responsible Party):
Johnny Moons, University Hospital, Gasthuisberg

Brief Summary:
Retrospective analysis of surgery and/or bronchial embolisation for pulmonary aspergilloma.

Condition or disease
Pulmonary Fungal Diseases

Detailed Description:
A retrospective chart analysis, based on the search results from a thoracic surgery database and an interventional radiology database. Outcome analysis of all surgically treated patients for a confirmed invasive aspergilloma. Comparisson with (preoperative) embolisation of the bronchial circulation.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Outcome After Surgical Treatment or Bronchial Embolisation in Aspergilloma of the Lung: a Single Center Experience.
Study Start Date : October 2013
Estimated Primary Completion Date : April 2014
Estimated Study Completion Date : June 2014

(preoperative) embolisation of the bronchial circulation
Any surgically treated patient with a functional lung resection (at least wedge resection)

Primary Outcome Measures :
  1. survival after treatment [ Time Frame: 10 years ]
    estimated 10 yaer survival after treatment for pulmonary aspergilloma

Secondary Outcome Measures :
  1. post treatment survival [ Time Frame: 90 days ]
    survival status at 90 days after initiation of treatment

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   1 Year to 89 Years   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

All patients in the database with following interventions will be screened for invasive aspergilloma in the final resection specimen:

Aspergilloma Fungal disease Lung bleeding Destroyed lung Empyema of the lung


Inclusion Criteria:

  • Histological proven Aspergilloma of the lung

Exclusion Criteria:

  • Treatment limited to the use of systemic antifungal agents

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01958710

Layout table for location information
University Hospital Leuven
Leuven, Belgium, 3000
Sponsors and Collaborators
University Hospital, Gasthuisberg
Layout table for investigator information
Principal Investigator: Herbert Decaluwé, MD UZ Leuven - dept. Thoracic Surgery
Principal Investigator: Laurence Bertrand, MSc Katholic University Leuven
Layout table for additonal information
Responsible Party: Johnny Moons, Datamanager Thoracic Surgery, University Hospital, Gasthuisberg
ClinicalTrials.gov Identifier: NCT01958710    
Other Study ID Numbers: ASPERLEU
First Posted: October 9, 2013    Key Record Dates
Last Update Posted: October 9, 2013
Last Verified: October 2013
Keywords provided by Johnny Moons, University Hospital, Gasthuisberg:
Catheterization, Bronchial
Additional relevant MeSH terms:
Layout table for MeSH terms
Lung Diseases, Fungal
Bacterial Infections and Mycoses
Respiratory Tract Infections
Lung Diseases
Respiratory Tract Diseases